General form of registration statement for all companies including face-amount certificate companies

Commitments and Contingencies (Tables)

v3.21.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Summary of Potential Milestone Payments

As consideration for its services, Sphaera has received a fixed fee of $160,000 and is entitled to the following milestone payments upon achievement of specified milestones:

 

Milestone Event

   Payment  

First dosing of patient in US Phase 1 trial

   $ 250,000  

US Phase 1 trial completion with endpoints met

     500,000  

US Phase 2 trial completion with endpoints met

     875,000  

FDA Approval

     4,000,000  
  

 

 

 

Total potential milestone payments

   $ 5,625,000